Triple‐negative breast cancer (TNBC), a heterogeneous subtype characterized by the absence of oestrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2), represents 12% to 17% of all breast carcinomas.2 Here, ERBB2 is linked to breast carcinoma.